We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Miss
Millie
Beament
+44 (0)20 3448 4773
m.beament@ucl.ac.uk
Prof
Nicholas
Fox
+44 (0)20 3448 4773
n.fox@ucl.ac.uk
Dementia
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
MRI is an essential part of the diagnostic workup in dementia, however, the time taken and cost limit its availability. Reduction in scan time will solve these issues. This study aims to develop an ultra-fast MRI scan cutting the gold-standard MRI scan from 30 to 7 minutes, with these scans providing non-inferior images to aid in dementia diagnosis.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
You can take part if:
You may not be able to take part if:
1. Unable to tolerate a routine MRI scan plus a 7-minute fast-MRI scan2. Unable to tolerate draw blood by venepuncture
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
Miss
Millie
Beament
+44 (0)20 3448 4773
m.beament@ucl.ac.uk
Prof
Nicholas
Fox
+44 (0)20 3448 4773
n.fox@ucl.ac.uk
The study is sponsored by University of London and funded by Biogen; Alzheimer's Society; Rosetrees Trust.
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Or CPMS 51048
You can print or share the study information with your GP/healthcare provider or contact the research team directly.